[
  {
    "title": "复旦张江(688505.SH)：累计获得政府补助863.09万元",
    "href": "http://stock.jrj.com.cn/2023/01/03203737256551.shtml",
    "datetime": "2023-01-03 20:37:17",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：马来酸噻吗洛尔乳膏用于治疗婴幼儿血管瘤的药物I期临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/11/17173437147173.shtml",
    "datetime": "2022-11-17 17:34:58",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)第三季度净利润7279.84万元、同比增长37.02%",
    "href": "http://stock.jrj.com.cn/2022/10/27212037091473.shtml",
    "datetime": "2022-10-27 21:20:20",
    "code": "688505"
  },
  {
    "title": "复旦张江：FZJ-003凝胶获药物临床试验申请受理通知书",
    "href": "http://stock.jrj.com.cn/2022/09/07164936980408.shtml",
    "datetime": "2022-09-07 16:49:41",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：外用JAK1选择性抑制剂FZJ-003凝胶用于治疗特应性皮炎的药物Ⅰ期临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/09/07164136980424.shtml",
    "datetime": "2022-09-07 16:41:06",
    "code": "688505"
  },
  {
    "title": "止盈转亏 复旦张江2022年半年度净亏损3597.45万元",
    "href": "http://stock.jrj.com.cn/2022/08/26092536939146.shtml",
    "datetime": "2022-08-26 09:25:56",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：上半年净亏损3597.45万元",
    "href": "http://stock.jrj.com.cn/2022/08/25221936937706.shtml",
    "datetime": "2022-08-25 22:19:32",
    "code": "688505"
  },
  {
    "title": "复旦张江：盐酸氨酮戊酸外用散II期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/08/24174836931201.shtml",
    "datetime": "2022-08-24 17:48:04",
    "code": "688505"
  },
  {
    "title": "复旦张江2022年半年预计亏损4000万-3000万同比由盈转亏 实施2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/08/15203236901674.shtml",
    "datetime": "2022-08-15 20:32:36",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：盐酸多柔比星脂质体注射液一致性评价申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/07/19171836825467.shtml",
    "datetime": "2022-07-19 17:18:02",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505)首次公开发行战略配售限售股于2022年6月20日上市流通",
    "href": "http://stock.jrj.com.cn/2022/06/13085636722757.shtml",
    "datetime": "2022-06-13 08:56:56",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：480万股限售股将于6月20日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/06/10165836719587.shtml",
    "datetime": "2022-06-10 16:58:48",
    "code": "688505"
  },
  {
    "title": "复旦张江：注射用FDA022抗体偶联剂I期临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/06/09132036715373.shtml",
    "datetime": "2022-06-09 13:20:47",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：注射用FDA022抗体偶联剂用于治疗晚期实体瘤的药物I期临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/06/08171236712801.shtml",
    "datetime": "2022-06-08 17:12:11",
    "code": "688505"
  },
  {
    "title": "复旦张江拟与上海汉都签订项目合作，构成关联交易",
    "href": "http://stock.jrj.com.cn/2022/05/27102836683683.shtml",
    "datetime": "2022-05-27 10:28:13",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：拟使用不超5.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/05/26200836682340.shtml",
    "datetime": "2022-05-26 20:08:13",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：拟就帕金森病治疗领域等与上海汉都进行项目合作并签署相关协议",
    "href": "http://stock.jrj.com.cn/2022/05/26200336682355.shtml",
    "datetime": "2022-05-26 20:03:15",
    "code": "688505"
  },
  {
    "title": "复旦张江2021年净利2.13亿同比增长29.53% 总经理王海波薪酬323万",
    "href": "http://stock.jrj.com.cn/2022/03/29145236127859.shtml",
    "datetime": "2022-03-29 14:52:38",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：2021年净利增29.53%至2.13亿元 拟10派0.7元",
    "href": "http://stock.jrj.com.cn/2022/03/28200135927626.shtml",
    "datetime": "2022-03-28 20:01:50",
    "code": "688505"
  },
  {
    "title": "复旦张江2021年净利2.13亿同比增长29.53% 产品销售回升",
    "href": "http://stock.jrj.com.cn/2022/02/25223034468604.shtml",
    "datetime": "2022-02-25 22:30:30",
    "code": "688505"
  },
  {
    "title": "复旦张江2名股东合计减持799.5万股 套现合计1.14亿 第三季度公司净利5312.88万",
    "href": "http://stock.jrj.com.cn/2022/01/10191034142427.shtml",
    "datetime": "2022-01-10 19:10:13",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：副总经理苏勇、赵大君已完成减持合计799.50万股",
    "href": "http://stock.jrj.com.cn/2022/01/10165034141612.shtml",
    "datetime": "2022-01-10 16:50:12",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)及子公司累计获得政府补助1912.66万元",
    "href": "http://stock.jrj.com.cn/2021/12/30203934088219.shtml",
    "datetime": "2021-12-30 20:39:31",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)获得政府补助1912.66万元",
    "href": "http://stock.jrj.com.cn/2021/12/30170434087186.shtml",
    "datetime": "2021-12-30 17:04:57",
    "code": "688505"
  },
  {
    "title": "复旦张江股东李军减持179.73万股 套现2657.88万 第三季度公司净利5312.88万",
    "href": "http://stock.jrj.com.cn/2021/12/27185034071941.shtml",
    "datetime": "2021-12-27 18:50:50",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：副总经理李军已减持179.73万股 减持计划实施完毕",
    "href": "http://stock.jrj.com.cn/2021/12/27163334070945.shtml",
    "datetime": "2021-12-27 16:33:31",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：注射用海姆泊芬治疗鲜红斑痣的新药临床试验申请获得美国FDA受理",
    "href": "http://stock.jrj.com.cn/2021/12/22174634047971.shtml",
    "datetime": "2021-12-22 17:46:41",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：奥贝胆酸片用于治疗原发性胆汁性胆管炎临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2021/12/13164334008850.shtml",
    "datetime": "2021-12-13 16:43:02",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：JAK1选择性抑制剂治疗溃疡性结肠炎的II期临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/19171533880633.shtml",
    "datetime": "2021-11-19 17:15:36",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：减持期过半 副总经理李军及苏勇已减持合计106.65万股",
    "href": "http://stock.jrj.com.cn/2021/11/12162533841199.shtml",
    "datetime": "2021-11-12 16:25:18",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：注射用FDA018抗体偶联剂I期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2021/11/05175833817512.shtml",
    "datetime": "2021-11-05 17:58:23",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：JAK1选择性抑制剂治疗特应性皮炎的药物临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/05175633817506.shtml",
    "datetime": "2021-11-05 17:56:41",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：第三季度净利降4.73%至5312.88万元",
    "href": "http://stock.jrj.com.cn/2021/10/28190633771221.shtml",
    "datetime": "2021-10-28 19:06:32",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：盐酸氨酮戊酸外用散用于治疗光化性角化病的药物临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/10/14163833691185.shtml",
    "datetime": "2021-10-14 16:38:41",
    "code": "688505"
  },
  {
    "title": "复旦张江2021年上半年净利6548.54万增长125.2% 药品销售情况好转",
    "href": "http://stock.jrj.com.cn/2021/08/11220233239516.shtml",
    "datetime": "2021-08-11 22:02:18",
    "code": "688505"
  },
  {
    "title": "复旦张江全资子公司预计投资约6亿元建设医药生产基地项目",
    "href": "http://stock.jrj.com.cn/2021/08/11200533239002.shtml",
    "datetime": "2021-08-11 20:05:41",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：拟投资6亿元建二期医药生产基地项目",
    "href": "http://stock.jrj.com.cn/2021/08/11170933238000.shtml",
    "datetime": "2021-08-11 17:09:15",
    "code": "688505"
  },
  {
    "title": "复旦张江：子公司拟6亿元建设二期医药生产基地",
    "href": "http://stock.jrj.com.cn/2021/08/11165933237912.shtml",
    "datetime": "2021-08-11 16:59:11",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)上半年净利升125.20%至6548.54万元",
    "href": "http://stock.jrj.com.cn/2021/08/11165833237910.shtml",
    "datetime": "2021-08-11 16:58:52",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)8月11日举行董事会议审批中期业绩",
    "href": "http://stock.jrj.com.cn/2021/07/30171933175978.shtml",
    "datetime": "2021-07-30 17:19:24",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：向258名激励对象首次授予3277万股限制性股票",
    "href": "http://stock.jrj.com.cn/2021/07/22161133135402.shtml",
    "datetime": "2021-07-22 16:11:02",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：3名董事、高管拟合计减持不超980万股",
    "href": "http://stock.jrj.com.cn/2021/07/20162533124545.shtml",
    "datetime": "2021-07-20 16:25:43",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)7月2日耗资95.93万港元回购18.9万股",
    "href": "http://stock.jrj.com.cn/2021/07/02183933034648.shtml",
    "datetime": "2021-07-02 18:39:26",
    "code": "688505"
  },
  {
    "title": "复旦张江：使用不超过7亿元暂时闲置募资进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/06/23064932979840.shtml",
    "datetime": "2021-06-23 06:49:00",
    "code": "688505"
  },
  {
    "title": "复旦张江：使用不超过7亿元暂时闲置募资进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/06/23064933105371.shtml",
    "datetime": "2021-06-23 06:49:00",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：薛燕退出上海诚渊 其所控制表决权下降至4.03%",
    "href": "http://stock.jrj.com.cn/2021/06/21164132969893.shtml",
    "datetime": "2021-06-21 16:41:03",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)A股每股现金红利0.05元 股权登记日6月22日",
    "href": "http://stock.jrj.com.cn/2021/06/15184632935941.shtml",
    "datetime": "2021-06-15 18:46:38",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：2020年度权益分派10派0.5元 股权登记日6月22日",
    "href": "http://stock.jrj.com.cn/2021/06/15180932935705.shtml",
    "datetime": "2021-06-15 18:09:15",
    "code": "688505"
  },
  {
    "title": "复旦张江：董事会审议通过回购H股的一般授权",
    "href": "http://stock.jrj.com.cn/2021/05/28110632834344.shtml",
    "datetime": "2021-05-28 11:06:51",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)获得回购H股一般授权 涉及不超3400万股H股",
    "href": "http://stock.jrj.com.cn/2021/05/27191932831437.shtml",
    "datetime": "2021-05-27 19:19:47",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：奥贝胆酸片的临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/04/23170532430703.shtml",
    "datetime": "2021-04-23 17:05:28",
    "code": "688505"
  },
  {
    "title": "复旦张江：公司近期在江苏省泰州市所拿土地用于公司未来产品的生产基地",
    "href": "http://stock.jrj.com.cn/2021/04/21112132415408.shtml",
    "datetime": "2021-04-21 11:21:14",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：拟授予激励对象限制性股票3800万股",
    "href": "http://stock.jrj.com.cn/2021/04/06182832320169.shtml",
    "datetime": "2021-04-06 18:28:25",
    "code": "688505"
  },
  {
    "title": "登陆科创板后业绩大降 复旦张江难改大起大落的“毛病”",
    "href": "http://stock.jrj.com.cn/2021/03/29082632238894.shtml",
    "datetime": "2021-03-29 08:26:00",
    "code": "688505"
  },
  {
    "title": "营利齐降！复旦张江去年净利润同比下滑近三成",
    "href": "http://stock.jrj.com.cn/2021/03/26110932221677.shtml",
    "datetime": "2021-03-26 11:09:27",
    "code": "688505"
  },
  {
    "title": "复旦张江2020年净利下滑27.58% 总经理王海波薪酬327.6万",
    "href": "http://stock.jrj.com.cn/2021/03/26000432219474.shtml",
    "datetime": "2021-03-26 00:04:04",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：授予董事会回购H股的一般性授权",
    "href": "http://stock.jrj.com.cn/2021/03/25213232218771.shtml",
    "datetime": "2021-03-25 21:32:37",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：拟总计2.665亿元取得上海汉都39.5663%的股权",
    "href": "http://stock.jrj.com.cn/2021/03/25210332218573.shtml",
    "datetime": "2021-03-25 21:03:01",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：2020年4月至今累计获1580.783万元政府补助",
    "href": "http://stock.jrj.com.cn/2021/03/25204032218377.shtml",
    "datetime": "2021-03-25 20:40:15",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)拟以9600万元超募资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/03/25203732218333.shtml",
    "datetime": "2021-03-25 20:37:07",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)2020年度净利润降27.58%至1.65亿元 拟10派0.5元",
    "href": "http://stock.jrj.com.cn/2021/03/25203032218043.shtml",
    "datetime": "2021-03-25 20:30:35",
    "code": "688505"
  },
  {
    "title": "复旦张江(01349.HK)公布2020年度业绩 建议派发股息每股0.05元",
    "href": "http://stock.jrj.com.cn/2021/03/25202532218000.shtml",
    "datetime": "2021-03-25 20:25:21",
    "code": "688505"
  },
  {
    "title": "复旦张江2020年度净利1.65亿下滑27.58% 疫情使得药品流通及医院患者就诊受阻",
    "href": "http://stock.jrj.com.cn/2021/02/25195732027536.shtml",
    "datetime": "2021-02-25 19:57:03",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：泰州复旦张江获注射用帕瑞昔布钠药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/02/25173732026573.shtml",
    "datetime": "2021-02-25 17:37:12",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)业绩快报：2020年度净利降27.58%至1.65亿元",
    "href": "http://stock.jrj.com.cn/2021/02/25173532026380.shtml",
    "datetime": "2021-02-25 17:35:41",
    "code": "688505"
  },
  {
    "title": "复旦张江(688505.SH)：520.55万股限售股12月21日解禁",
    "href": "http://stock.jrj.com.cn/2020/12/09173231450076.shtml",
    "datetime": "2020-12-09 17:32:37",
    "code": "688505"
  },
  {
    "title": "复旦张江前三季度净利8484.79万下滑30.15% 销售量下降",
    "href": "http://stock.jrj.com.cn/2020/10/31143531181183.shtml",
    "datetime": "2020-10-31 14:35:14",
    "code": "688505"
  },
  {
    "title": "复旦张江：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/30011031162872.shtml",
    "datetime": "2020-10-30 01:10:00",
    "code": "688505"
  },
  {
    "title": "复旦张江上半年营收降40%净利降68% 海通证券保荐",
    "href": "http://stock.jrj.com.cn/2020/08/26165330594888.shtml",
    "datetime": "2020-08-26 16:53:00",
    "code": "688505"
  },
  {
    "title": "DRG付费实施在即 复旦张江科创板上市首日涨幅逾300% | 医资周报",
    "href": "http://stock.jrj.com.cn/2020/06/19172929967718.shtml",
    "datetime": "2020-06-19 17:29:26",
    "code": "688505"
  },
  {
    "title": "复旦张江今日上市 发行价格8.95元/股",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/19080729962845.shtml",
    "datetime": "2020-06-19 08:07:33",
    "code": "688505"
  },
  {
    "title": "领先光动力技术傍身 复旦张江登陆科创板",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/19054129961285.shtml",
    "datetime": "2020-06-19 05:41:08",
    "code": "688505"
  },
  {
    "title": "复旦张江中签号出炉 中签号码共57254个",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/10072229886433.shtml",
    "datetime": "2020-06-10 07:22:20",
    "code": "688505"
  },
  {
    "title": "【兑奖啦】复旦张江、聚合顺网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2020/06/09192129882738.shtml",
    "datetime": "2020-06-09 19:21:55",
    "code": "688505"
  },
  {
    "title": "医保局就基本医保医用耗材管理征求意见 复旦张江即将登陆科创板 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/06/09180829882324.shtml",
    "datetime": "2020-06-09 18:08:55",
    "code": "688505"
  },
  {
    "title": "上海医药参股公司复旦张江首次公开发行A股股票并在科创板上市发行",
    "href": "http://stock.jrj.com.cn/2020/06/09085529877818.shtml",
    "datetime": "2020-06-09 08:55:41",
    "code": "688505"
  },
  {
    "title": "今日新股申购：聚合顺、复旦张江",
    "href": "http://stock.jrj.com.cn/2020/06/08091229869059.shtml",
    "datetime": "2020-06-08 09:12:00",
    "code": "688505"
  },
  {
    "title": "复旦张江今日申购 科创板首现累计投标询价",
    "href": "http://stock.jrj.com.cn/2020/06/08004429863023.shtml",
    "datetime": "2020-06-08 00:44:22",
    "code": "688505"
  },
  {
    "title": "科创板新股复旦张江6月8日申购宝典",
    "href": "http://stock.jrj.com.cn/kcb/2020/06/05140529852120.shtml",
    "datetime": "2020-06-05 14:05:42",
    "code": "688505"
  },
  {
    "title": "复旦张江第一个“吃螃蟹” 科创板首现IPO累计投标询价",
    "href": "http://stock.jrj.com.cn/2020/05/28233829790831.shtml",
    "datetime": "2020-05-28 23:38:21",
    "code": "688505"
  },
  {
    "title": "复旦张江：研发实力雄厚 业绩持续放量",
    "href": "http://stock.jrj.com.cn/2020/05/21201629733084.shtml",
    "datetime": "2020-05-21 20:16:00",
    "code": "688505"
  },
  {
    "title": "复旦张江研发合作或存利益输送 商业贿赂“旧伤”曝光“泰凌系”历史合作之谜",
    "href": "http://stock.jrj.com.cn/2020/05/21093529729571.shtml",
    "datetime": "2020-05-21 09:35:00",
    "code": "688505"
  },
  {
    "title": "复旦张江科创板IPO注册生效 将实现A+H两地同时上市",
    "href": "http://stock.jrj.com.cn/2020/05/18153129702700.shtml",
    "datetime": "2020-05-18 15:31:18",
    "code": "688505"
  },
  {
    "title": "上交所：科创板拟上市公司复旦张江提交注册",
    "href": "http://stock.jrj.com.cn/2020/04/13170729275381.shtml",
    "datetime": "2020-04-13 17:07:00",
    "code": "688505"
  },
  {
    "title": "复旦张江过会：今年科创板过会第17家 海通证券过2单",
    "href": "http://stock.jrj.com.cn/2020/04/03220329190040.shtml",
    "datetime": "2020-04-03 22:03:00",
    "code": "688505"
  },
  {
    "title": "上交所：秦川物联、复旦张江科创板首发过会",
    "href": "http://stock.jrj.com.cn/2020/04/03170929188025.shtml",
    "datetime": "2020-04-03 17:09:00",
    "code": "688505"
  },
  {
    "title": "上交所：秦川物联、复旦张江科创板首发事项推迟上会",
    "href": "http://stock.jrj.com.cn/2020/03/25171129106861.shtml",
    "datetime": "2020-03-25 17:11:00",
    "code": "688505"
  },
  {
    "title": "复旦张江、孚能科技、神州细胞3月31日科创板上会",
    "href": "http://stock.jrj.com.cn/2020/03/23090629080341.shtml",
    "datetime": "2020-03-23 09:06:00",
    "code": "688505"
  },
  {
    "title": "科创板上市委：复旦张江首发3月31日上会",
    "href": "http://stock.jrj.com.cn/2020/03/20172529070197.shtml",
    "datetime": "2020-03-20 17:25:00",
    "code": "688505"
  },
  {
    "title": "复旦张江成科创板首家被暂缓审议企业 事涉5000万补偿金",
    "href": "http://stock.jrj.com.cn/2019/10/21101028275385.shtml",
    "datetime": "2019-10-21 10:10:19",
    "code": "688505"
  },
  {
    "title": "复旦张江积极落实审核意见 等待重新上会审议",
    "href": "http://stock.jrj.com.cn/2019/10/20200928272448.shtml",
    "datetime": "2019-10-20 20:09:44",
    "code": "688505"
  },
  {
    "title": "有关注事项需进一步核实 复旦张江成科创板首家被暂缓审议企业",
    "href": "http://stock.jrj.com.cn/2019/10/19091828270588.shtml",
    "datetime": "2019-10-19 09:18:03",
    "code": "688505"
  },
  {
    "title": "科创板上市委暂缓审议复旦张江首发上市",
    "href": "http://stock.jrj.com.cn/kcb/2019/10/19043228270245.shtml",
    "datetime": "2019-10-19 04:32:16",
    "code": "688505"
  },
  {
    "title": "复旦张江成首例科创板上市委暂缓审议企业",
    "href": "http://stock.jrj.com.cn/2019/10/18225428269955.shtml",
    "datetime": "2019-10-18 22:54:00",
    "code": "688505"
  },
  {
    "title": "上交所：东方基因科创板首发过会 复旦张江暂缓审议",
    "href": "http://stock.jrj.com.cn/kcb/2019/10/18220128269852.shtml",
    "datetime": "2019-10-18 22:01:15",
    "code": "688505"
  },
  {
    "title": "上交所：东方基因科创板首发过会 复旦张江暂缓审议",
    "href": "http://stock.jrj.com.cn/2019/10/18215228269826.shtml",
    "datetime": "2019-10-18 21:52:00",
    "code": "688505"
  },
  {
    "title": "复旦张江等两公司科创板首发申请10月18日上会",
    "href": "http://stock.jrj.com.cn/2019/10/10175628227728.shtml",
    "datetime": "2019-10-10 17:56:00",
    "code": "688505"
  },
  {
    "title": "每经小强快讯：上海复旦张江生物医药股份有限公司科创板之路跌宕起伏，发行中止了",
    "href": "http://stock.jrj.com.cn/2019/07/31181627909693.shtml",
    "datetime": "2019-07-31 18:16:23",
    "code": "688505"
  },
  {
    "title": "复旦张江：更新中期业绩 申请中止科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/07/31174427909607.shtml",
    "datetime": "2019-07-31 17:44:00",
    "code": "688505"
  },
  {
    "title": "复旦张江冲刺科创板 上海医药持股22.77%",
    "href": "http://stock.jrj.com.cn/2019/05/13210127565403.shtml",
    "datetime": "2019-05-13 21:01:00",
    "code": "688505"
  },
  {
    "title": "上交所受理复旦张江上市申请 公司港股股价上涨4.62%",
    "href": "http://stock.jrj.com.cn/2019/05/13182327564860.shtml",
    "datetime": "2019-05-13 18:23:57",
    "code": "688505"
  },
  {
    "title": "复旦张江冲击科创板上市 上海医药持股近23%",
    "href": "http://stock.jrj.com.cn/2019/05/13175327564740.shtml",
    "datetime": "2019-05-13 17:53:13",
    "code": "688505"
  },
  {
    "title": "上交所受理复旦张江的科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/05/13174027564718.shtml",
    "datetime": "2019-05-13 17:40:00",
    "code": "688505"
  },
  {
    "title": "上交所今日受理复旦张江的科创板上市申请",
    "href": "http://stock.jrj.com.cn/2019/05/13173327564679.shtml",
    "datetime": "2019-05-13 17:33:42",
    "code": "688505"
  },
  {
    "title": "每经小强快讯：进军科创板，上海复旦张江生物医药股份有限公司申请已获上交所受理",
    "href": "http://stock.jrj.com.cn/2019/05/13173127564675.shtml",
    "datetime": "2019-05-13 17:31:21",
    "code": "688505"
  },
  {
    "title": "每经小强快讯：上海复旦张江生物医药股份有限公司科创板首次公开发行股票招股说明书（申报稿）",
    "href": "http://stock.jrj.com.cn/2019/05/13173127564676.shtml",
    "datetime": "2019-05-13 17:31:21",
    "code": "688505"
  },
  {
    "title": "恒生指数高开0.13% 复旦张江大涨18%",
    "href": "http://stock.jrj.com.cn/2019/03/11092627146290.shtml",
    "datetime": "2019-03-11 09:26:00",
    "code": "688505"
  },
  {
    "title": "港股上市公司复旦张江拟登陆科创板",
    "href": "http://stock.jrj.com.cn/2019/03/08213327138053.shtml",
    "datetime": "2019-03-08 21:33:15",
    "code": "688505"
  },
  {
    "title": "公告精选：复旦张江计划在科创板发行A股；德展健康与汉麻投资签署合作协议",
    "href": "http://stock.jrj.com.cn/2019/03/08205227137964.shtml",
    "datetime": "2019-03-08 20:52:00",
    "code": "688505"
  },
  {
    "title": "港股复旦张江：建议发行A股并于科创板上市",
    "href": "http://stock.jrj.com.cn/2019/03/08175627137420.shtml",
    "datetime": "2019-03-08 17:56:00",
    "code": "688505"
  },
  {
    "title": "复旦张江港交所公告:建议发行A股并在科创板上市",
    "href": "http://stock.jrj.com.cn/2019/03/08175327137369.shtml",
    "datetime": "2019-03-08 17:53:45",
    "code": "688505"
  },
  {
    "title": "上海医药：与复旦张江合作研发创新药物",
    "href": "http://stock.jrj.com.cn/2011/02/2321179273228.shtml",
    "datetime": "2011-02-23 21:17:11",
    "code": "688505"
  }
]